A live attenuated virus-based intranasal COVID-19 vaccine provides rapid, prolonged, and broad protection against SARS-CoV-2 J Chen, P Wang, L Yuan, L Zhang, L Zhang, H Zhao, C Chen, X Wang, ... Science bulletin 67 (13), 1372-1387, 2022 | 68 | 2022 |
A recombinant spike protein subunit vaccine confers protective immunity against SARS-CoV-2 infection and transmission in hamsters Y Wu, X Huang, L Yuan, S Wang, Y Zhang, H Xiong, R Chen, J Ma, R Qi, ... Science translational medicine 13 (606), eabg1143, 2021 | 65 | 2021 |
Gender associates with both susceptibility to infection and pathogenesis of SARS-CoV-2 in Syrian hamster L Yuan, H Zhu, M Zhou, J Ma, R Chen, Y Chen, L Chen, K Wu, M Cai, ... Signal transduction and targeted therapy 6 (1), 136, 2021 | 64 | 2021 |
Urgency and necessity of Epstein-Barr virus prophylactic vaccines L Zhong, C Krummenacher, W Zhang, J Hong, Q Feng, Y Chen, Q Zhao, ... npj Vaccines 7 (1), 159, 2022 | 18 | 2022 |
Protective anti-gB neutralizing antibodies targeting two vulnerable sites for EBV-cell membrane fusion X Zhang, J Hong, L Zhong, Q Wu, S Zhang, Q Zhu, H Chen, D Wei, R Li, ... Proceedings of the National Academy of Sciences 119 (32), e2202371119, 2022 | 15 | 2022 |
Affinity Exploration of SARS-CoV-2 RBD Variants to mAb-Functionalized Plasmonic Metasurfaces for Label-Free Immunoassay Boosting F Li, J Hong, C Guan, K Chen, Y Xie, Q Wu, J Chen, B Deng, J Shen, ... ACS nano, 2023 | 14 | 2023 |
Rabbit monoclonal antibody specifically recognizing a linear epitope in the RBD of SARS-CoV-2 spike protein J Hong, Q Wang, Q Wu, J Chen, X Wang, Y Wang, Y Chen, N Xia Vaccines 9 (8), 829, 2021 | 10 | 2021 |
Adefovir dipivoxil efficiently inhibits the proliferation of pseudorabies virus in vitro and in vivo G Wang, R Chen, P Huang, J Hong, J Cao, Q Wu, W Zheng, L Lin, Q Han, ... Antiviral Research 186, 105014, 2021 | 10 | 2021 |
A SCID mouse-human lung xenograft model of SARS-CoV-2 infection W Fu, W Wang, L Yuan, Y Lin, X Huang, R Chen, M Cai, C Liu, L Chen, ... Theranostics 11 (13), 6607, 2021 | 10 | 2021 |
A Neutralizing Antibody Targeting gH Provides Potent Protection against EBV Challenge In Vivo J Hong, L Zhong, Q Zheng, Q Wu, Z Zha, D Wei, H Chen, W Zhang, ... Journal of Virology 96 (8), e00075-22, 2022 | 9 | 2022 |
Antibody generation and immunogenicity analysis of EBV gp42 N-terminal region J Hong, D Wei, Q Wu, L Zhong, K Chen, Y Huang, W Zhang, J Chen, ... Viruses 13 (12), 2380, 2021 | 9 | 2021 |
Establishment of a rapid ELISPOT assay for influenza virus titration and neutralizing antibody detection G Wang, P Huang, J Hong, R Fu, Q Wu, R Chen, L Lin, Q Han, H Chen, ... Journal of Medical Virology 93 (6), 3455-3464, 2021 | 8 | 2021 |
Glycoprotein B antibodies completely neutralize EBV infection of B Cells J Hong, D Wei, L Zhong, Q Wu, K Chen, W Zhang, Y Yang, J Chen, N Xia, ... Frontiers in Immunology 13, 2022 | 7 | 2022 |
Characterization and immunogenicity of SARS-CoV-2 spike proteins with varied glycosylation T Deng, T Li, G Chen, Y Zhu, L Xu, Y Lin, H Sun, H Zhang, Q Fang, ... Vaccine 40 (47), 6839-6848, 2022 | 6 | 2022 |
A high-throughput neutralizing assay for antibodies and sera evaluation against Epstein-Barr virus L Zhong, C Krummenacher, W Zhang, J Hong, Q Feng, Q Zhao, Y Chen, ... Virology Journal 19 (1), 1-15, 2022 | 5 | 2022 |
Dose-dependent outcome of EBV infection of humanized mice based on green Raji unit (GRU) doses H Chen, L Zhong, W Zhang, S Zhang, J Hong, X Zhou, X Zhang, Q Feng, ... Viruses 13 (11), 2184, 2021 | 5 | 2021 |
A live attenuated influenza virus-vectored intranasal COVID-19 vaccine provides rapid, prolonged, and broad protection against SARS-CoV-2 infection J Chen, P Wang, L Yuan, L Zhang, L Zhang, H Zhao, C Chen, Y Chen, ... bioRxiv, 2021.11. 13.468472, 2021 | 3 | 2021 |
The potential of swine pseudorabies virus attenuated vaccine for oncolytic therapy against malignant tumors G Wang, J Cao, M Gui, P Huang, L Zhang, R Qi, R Chen, L Lin, Q Han, ... Journal of Experimental & Clinical Cancer Research 42 (1), 284, 2023 | 2 | 2023 |
Sterilizing immunity against SARS-CoV-2 in hamsters conferred by a novel recombinant subunit vaccine Y Wu, X Huang, L Yuan, S Wang, Y Zhang, H Xiong, R Chen, J Ma, R Qi, ... bioRxiv, 2020.12. 18.423552, 2020 | 1 | 2020 |
Transcriptional signature of durable effector T cells elicited by a replication defective HCMV vaccine X Ye, DJH Shih, Z Ku, J Hong, DF Barrett, RE Rupp, N Zhang, TM Fu, ... npj Vaccines 9 (1), 70, 2024 | | 2024 |